Virtual Senior Center (VSC)

July 15, 2026 updated by: Matthew Kreuter, Washington University School of Medicine

Achieving Digital Equity for Health Improvement in a Virtual Senior Center

In a 3-group trial with randomization and follow-up for 12 months, we will compare use of the VSC as well as health and quality of life outcomes among 650 older adults in St. Louis who receive either: (1) home delivered meals AND a GrandPad; (2) home-delivered meals but no GrandPad for 6 months; and (3) in person meals at senior center but no GrandPad.

Study Overview

Detailed Description

The aims of the study are:

  1. Recruit 650 older adults in St. Louis into the study - 400 home-delivered meal recipients and 250 receiving in-person meals at senior centers. Describe baseline differences between the two groups in use of senior center programming, technology access and use, and health and quality of life outcomes.
  2. Randomly assign the 400 home-delivered meal recipients to get a GrandPad immediately (GP) or 6 months later (GP-6). Compare the GP and GP-6 groups to in-person meal recipients (IP) on: (A) VSC engagement at 6- and 12-month follow-up; and (B) health and quality of life outcomes at 6- and 12-month follow-up.
  3. Examine longitudinal changes and hypothesized mediating pathways using 5 waves of data from baseline, 3-,6-,9- and 12-month follow-up. Specifically: (A) in the GP-6 group only, compare VSC engagement, health and quality of life outcomes at 6-month follow-up (a period in which they did not have a GrandPad) to 12-month follow-up (a period in which they did have a GrandPad); (B) examine 12-month trends in GrandPad and VSC engagement, health and quality of life outcomes within and across groups; and (C) test mediation of hypothesized explanatory variables from the study's conceptual framework to examine potential causal pathways for health and quality of life outcomes.

Study Type

Interventional

Enrollment (Estimated)

650

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63101
        • Washington University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Current Home-delivered meal client with Aging Ahead

Exclusion Criteria:

  • Under age 65

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GrandPad1
This group will receive a GrandPad right away after they complete the baseline survey
The Virtual Senior Center engages older adults in programs and services online with the help of a GrandPad.
Other: GrandPad2 - 6mo
Delayed interventional. This group will receive a GrandPad after 6 months.
The Virtual Senior Center engages older adults in programs and services online with the help of a GrandPad.
Active Comparator: Congregate
This group will not receive a GrandPad but will get access to the Virtual Senior Center
Participants will be given information to access the website when they are able from their own phone, tablet, or computer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Social Isolation Scale in Older Adults (Nicholson et al., 2020; The Gerontologist)
Time Frame: 12 month
This 6-item questionnaire measures the extent to which an individual feels socially unconnected, using 2 related constructs (3 items per construct): quantity of social contacts and sense of relationship. The response options for social contacts ranges from 1 (none) to 5 (6 or more) and the sense of relationship ranges from 1(strongly disagree) to 5 (strongly agree). The possible summed scores range from 6 to 30, with higher scores indicating less social isolation.
12 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Digital Social Participation (Anderberg et al., 2021; JMIR)
Time Frame: 12 month
This 6-item questionnaire measures extent to which someone feels that digital technology is beneficial in their life. Response options range from 1 (strongly disagree) to 5 (strongly agree), so total summed scores range from 6 -30. A higher scores indicates more positive perceptions of digital technology.
12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew Kreuter, PhD, MPH, Washington University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

April 13, 2025

First Submitted That Met QC Criteria

April 18, 2025

First Posted (Actual)

April 27, 2025

Study Record Updates

Last Update Posted (Actual)

July 17, 2026

Last Update Submitted That Met QC Criteria

July 15, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 202408007
  • OT2HL158287 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The raw survey response data including dates collected, as well as participant ID codes generated for this study will be shared in order to link the five waves of survey data as well as documentation of participation. All respondent identifiers (e.g., names, addresses) will be removed before sharing. Final de-identified intervention data and Common Survey 4 data will be shared with the CEAL (community engagement Alliance) Technical Assistance Team. Other CEAL researchers will be allowed to request common survey data.

We will share all publicly accessible files on WashU Research Data, an institutional repository managed by the Washington University in St. Louis Libraries that uses a cloud-based hosted repository service called TIND as its platform. TIND is based on the open-source Invenio software developed at the research institute CERN to manage its own scholarly output. TIND uses an OAIS-compliant approach to preservation, with redundancy backup, conversion to archival file format

IPD Sharing Time Frame

3/31/28 - indefinitely

IPD Sharing Access Criteria

Users must register with the repository and agree to the License specified for the project. This license will allow users to adapt and build upon the materials in any format for noncommercial purposes only and so long as attribution is given to the original creators and grant funding. Any adapted or new data formats and accompanying descriptions will also need to be publicly available under identical terms as the original. Additionally, the license will protect study participants by limiting data use to scientific research and aggregate statistical reporting, prohibit attempts to identify study participants, and require immediate reporting of any identification of study participant's identity. Data users also agree not to share or redistribute any data downloads.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe